Learn More
Medchemexpress LLC Stearoylcarnitine | 25597-09-5 | 99.9% | 427.66 | 50 MG

Supplier: Medchemexpress LLC HY11320250MG
Stearoylcarnitine is a fatty ester lipid molecule and an endogenous metabolite. It can act as a PKC inhibitor and accumulates in β cells, leading to arrest of insulin synthesis and energy deficiency in type 2 diabetes mouse models. It also inhibits lecithin cholesterol acyltransferase (LCAT) in rat and rabbit plasma and serves as a metabolomics biomarker for Parkinson's disease. Additionally, it is a less potent inhibitor of GlyT2.
- Functions as an endogenous metabolite.
- Acts as a PKC inhibitor.
- Accumulates in beta cells, impairing insulin synthesis.
- Inhibits lecithin cholesterol acyltransferase (LCAT) in rat and rabbit plasma.
- Serves as a metabolomics biomarker for Parkinson's disease.
- Less potent inhibitor of GlyT2.
- Impairs mitochondrial energy metabolism in MIN6 cells.
- Alters brain acylcarnitine levels in a mouse model of hypoxic-ischemic brain injury.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.